# Rivastigmine Tartrate

NDC: 62135-901
Generic name: Rivastigmine Tartrate
Labeler / Manufacturer: Chartwell RX, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20170928

FDA application: ANDA207797

## Active ingredients

- RIVASTIGMINE TARTRATE: 3 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62135-901"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62135-901
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2bb5e0d6-f677-4021-9888-3ff90979ef7d